(15024477), J. A. L., (15049851), R. T. S., (15049854), M. F. W., (15049857), F. I. A., (15049860), J. D. R., (15049863), L. W., . . . (15049920), J. G. (2025). Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma.
Цитирование в стиле Чикаго (17-е изд.)(15024477), John A. Ligon, et al. Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma. 2025.
Цитирование MLA (9-е изд.)(15024477), John A. Ligon, et al. Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma. 2025.